Baratto Claudia, Caravita Sergio, Faini Andrea, Perego Giovanni Battista, Senni Michele, Badano Luigi P, Parati Gianfranco
Department of Cardiovascular, Neural and Metabolic Sciences, Istituto Auxologico Italiano IRCCS, Ospedale San Luca, Milano, Italy.
Department of Medicine and Surgery, University of Milano-Bicocca, Milano, Italy.
J Appl Physiol (1985). 2021 May 1;130(5):1470-1478. doi: 10.1152/japplphysiol.00710.2020. Epub 2021 Mar 25.
Survivors from COVID-19 pneumonia can present with persisting multisystem involvement (lung, pulmonary vessels, heart, muscle, red blood cells) that may negatively affect exercise capacity. We sought to determine the extent and the determinants of exercise limitation in patients with COVID-19 at the time of hospital discharge. Eighteen consecutive patients with COVID-19 and 1:1 age-, sex-, and body mass index-matched controls underwent: spirometry, echocardiography, cardiopulmonary exercise test and exercise echocardiography for the study of pulmonary circulation. Arterial blood was sampled at rest and during exercise in patients with COVID-19. Patients with COVID-19 lie roughly on the same oxygen consumption isophlets than controls both at rest and during submaximal exercise, thanks to supernormal cardiac output ( < 0.05). Oxygen consumption at peak exercise was reduced by 30% in COVID-19 ( < 0.001), due to a peripheral extraction limit. In addition, within COVID-19 patients, hemoglobin content was associated with peak oxygen consumption ( = 0.46, = 0.002). Respiratory reserve was not exhausted (median [IRQ], 0.59 [0.15]) in spite of moderate reduction of forced vital capacity (79 ± 40%). Pulmonary artery pressure increase during exercise was not different between patients and controls. Ventilatory equivalents for carbon dioxide were higher in patients with COVID-19 than in controls (39.5 [8.5] vs. 29.5 [8.8], < 0.001), and such an increase was mainly explained by increased chemosensitivity. When recovering from COVID-19, patients present with reduced exercise capacity and augmented exercise hyperventilation. Peripheral factors, including anemia and reduced oxygen extraction by peripheral muscles were the major determinants of deranged exercise physiology. Pulmonary vascular function seemed unaffected, despite restrictive lung changes. At the time of hospital discharge, patients with COVID-19 present with reduced functional capacity and exercise hyperventilation. Peripheral factors, namely reduced oxygen extraction (myopathy) and anemia, which are not fully compensated by a supernormal cardiac output response, account for exercise limitation before exhaustion of the respiratory reserve. Enhanced chemoreflex sensitivity, rather increased dead space, mainly accounts for exercise hyperventilation. The pulmonary vascular response to exercise circulation of survived patients with COVID-19 does not present major pathological changes.
新冠病毒肺炎幸存者可能会出现多系统持续受累(肺部、肺血管、心脏、肌肉、红细胞),这可能会对运动能力产生负面影响。我们试图确定新冠病毒感染患者出院时运动受限的程度及决定因素。连续纳入18例新冠病毒感染患者,并按年龄、性别和体重指数1:1匹配对照,进行了:肺活量测定、超声心动图、心肺运动试验以及用于研究肺循环的运动超声心动图检查。对新冠病毒感染患者在静息和运动期间采集动脉血样。新冠病毒感染患者在静息和次极量运动时,其氧耗量大致与对照组处于相同的等氧耗量曲线上,这得益于超常的心输出量(P<0.05)。由于外周摄取限制,新冠病毒感染患者运动峰值时的氧耗量降低了30%(P<0.001)。此外,在新冠病毒感染患者中,血红蛋白含量与运动峰值氧耗量相关(r=0.46,P=0.002)。尽管用力肺活量中度降低(79±40%),呼吸储备并未耗尽(中位数[四分位间距],0.59[0.15])。患者与对照组运动期间肺动脉压升高无差异。新冠病毒感染患者的二氧化碳通气当量高于对照组(39.5[8.5]对29.5[8.8],P<0.001),这种升高主要由化学敏感性增加所致。从新冠病毒感染中恢复时,患者运动能力下降且运动性通气过度增强。外周因素,包括贫血和外周肌肉氧摄取减少,是运动生理学紊乱的主要决定因素。尽管存在限制性肺改变,但肺血管功能似乎未受影响。在出院时,新冠病毒感染患者功能能力下降且存在运动性通气过度。外周因素,即氧摄取减少(肌病)和贫血,未被超常的心输出量反应完全代偿,是呼吸储备耗尽前运动受限的原因。化学反射敏感性增强而非死腔增加,是运动性通气过度的主要原因。新冠病毒感染康复患者的肺血管对运动循环的反应未出现重大病理变化。